-- Lifecore Biomedical (LFCR) has an average rating of overweight and mean price target of $6.67 according to analysts polled by FactSet.
(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)
Price: $5.13, Change: $+0.01, Percent Change: +0.20%
Collins Foods (ASX:CKF) said conditions precedent for the transition of 20 Taco Bell restaurants to a new partnership arrangement between an affiliated company of Taco Bell and Restaurant Brands Australia have been satisfied, according to a Friday Australian bourse filing.The company said the transaction remains subject to other customary conditions, including landlord consents, a store-based employment threshold, and Australian Competition and Consumer Commission (ACCC) clearance, with completion expected between June and August, depending on regulatory approval timelines.
NZX (NZE:NZX) reported first-quarter revenue of NZ$32.7 million, up 5% from NZ$31.1 million in the year-ago period, according to a Friday filing on the bourse.The number of total listed securities on the exchange as of March 31 fell 1.8% year over year to 323, per the filing.
Avita Medical (ASX:AVH) has appointed Cary Vance as chief executive, effective immediately, according to a Friday Australian bourse filing.Vance has been acting as interim CEO since October 2025, per the filing.The company also appointed Jan Stern Reed as chair with immediate effect, the filing added.